AS1810722
AS1810722 is an orally active and potent STAT6 inhibitor (IC50 :1.9 nM) . AS1810722 shows a good profile of CYP3A4 inhibition. AS1810722, a derivative of fused bicyclic pyrimidine, has the potential for allergic diseases such as asthma and atopic diseases research.
Product Specifications
CAS Number
909561-15-5
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
477.52
Molecular Formula
C25H25F2N7O
Notes
Research use only, not for human use.
Receptor
CYP3A4|STAT6
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bs-20395R-PE-Cy7 100 µL
Thrombomodulin Polyclonal Antibody, PE-Cy7 Conjugated
Sign In for Pricing
View Details MBS1339429-01 0.02 mg (E-Coli)
Recombinant Frankia sp. Probable DNA repair protein Francci3_3805 (Francci3_3805)
Sign In for Pricing
View Details